{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:23:22Z","timestamp":1793211802057,"version":"4.5.0"},"reference-count":115,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T00:00:00Z","timestamp":1569196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Thyroid nodules are common in the adult population where a majority are benign and only 4.0% to 6.5% are malignant. Fine needle aspiration (FNA) is a key method used in the early stages to evaluate and triage patients with thyroid nodules. While a definitive cytological diagnosis is provided in more than 70\u201375% of all thyroid FNA cases, the group of indeterminate lesions offers a challenge in terms of interpretation and clinical management. Molecular testing platforms have been developed, are recognized as an option by the 2015 American Thyroid Association Guidelines, and are frequently used in conjunction with FNA as an integral part of the cytologic evaluation. In this review, the utility of molecular testing options for nodules assigned to the group of indeterminate thyroid FNAs is described.<\/jats:p>","DOI":"10.3390\/genes10100736","type":"journal-article","created":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T11:02:00Z","timestamp":1569236520000},"page":"736","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["The Role of Molecular Testing for the Indeterminate Thyroid FNA"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3819-4229","authenticated-orcid":false,"given":"Esther Diana","family":"Rossi","sequence":"first","affiliation":[{"name":"Division of Anatomic Pathology and Histology, Catholic University of Sacred Heart, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liron","family":"Pantanowitz","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA 15232, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Faquin","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,9,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/1097-0142(20001225)90:6<325::AID-CNCR1>3.0.CO;2-U","article-title":"Fine-needle aspiration cytology of the thyroid: An appraisal","volume":"90","author":"Cramer","year":"2000","journal-title":"Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1530\/EJE-08-0135","article-title":"Thyroid nodules: A review of current guidelines, practices, and prospects","volume":"159","author":"Gharib","year":"2008","journal-title":"Eur. J. Endocrinol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/cen.12806","article-title":"BRAF-mutated carcinomas among thyroid nodules with prior indeterminate FNA report: A systematic review and meta-analysis","volume":"84","author":"Trimboli","year":"2016","journal-title":"Clin. Endocrinol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.surg.2011.09.006","article-title":"The impact of atypia\/follicular lesion of undetermined significance on the rate of malignancy in thyroid fine-needle aspiration: Evaluation of the Bethesda System for Reporting Thyroid Cytopathology","volume":"150","author":"Broome","year":"2011","journal-title":"Surgery"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/1097-0142(20001225)90:6<357::AID-CNCR6>3.0.CO;2-4","article-title":"Usefulness of fine-needle aspiration in the diagnosis of thyroid carcinoma: A retrospective study in 37,895 patients","volume":"90","author":"Ravetto","year":"2000","journal-title":"Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/1097-0142(20000825)90:4<239::AID-CNCR7>3.0.CO;2-S","article-title":"Fine-needle aspiration of the thyroid. Importance of an indeterminate diagnostic category","volume":"90","author":"Poller","year":"2000","journal-title":"Cancer Cytopathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1089\/thy.2013.0317","article-title":"Malignancy Rate in Thyroid Nodules Classified as Bethesda Category III (AUS\/FLUS)","volume":"24","author":"Ho","year":"2014","journal-title":"Thyroid"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000334200","article-title":"Reclassifying Formerly Indeterminate Thyroid FNAs Using the Bethesda System Reduces the Number of Inconclusive Cases","volume":"56","author":"Song","year":"2012","journal-title":"Acta Cytol."},{"key":"ref_10","first-page":"298","article-title":"Thyroid fine-needle aspiration with atypia of undetermined significance: A necessary or optional category?","volume":"117","author":"Shi","year":"2009","journal-title":"Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s12022-015-9386-3","article-title":"Cytopathology of Follicular Cell Nodules","volume":"26","author":"Damiani","year":"2015","journal-title":"Endocr. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1245\/s10434-012-2601-2","article-title":"Management of Thyroid Nodules with Atypical Cytology on Fine-needle Aspiration Biopsy","volume":"20","author":"Nagarkatti","year":"2013","journal-title":"Ann. Surg. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1159\/000333232","article-title":"Spectrum of Risk of Malignancy in Subcategories of \u2018Atypia of Undetermined Significance\u2019","volume":"55","author":"Olson","year":"2011","journal-title":"Acta Cytol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/dc.21790","article-title":"Thyroid follicular lesion of undetermined significance: Evaluation of the risk of malignancy using the two-tier sub-classification","volume":"40","author":"Horne","year":"2012","journal-title":"Diagn. Cytopathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/cncy.21396","article-title":"The prediction of malignant risk in the category \u201catypia of undetermined significance\/follicular lesion of undetermined significance\u201d of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results","volume":"122","author":"Hyeon","year":"2014","journal-title":"Cancer Cytopathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/cyt.12021","article-title":"Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology","volume":"24","author":"Dincer","year":"2013","journal-title":"Cytopathology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/cncy.21434","article-title":"What is the malignancy risk for atypia of undetermined significance? Three years\u2019 experience at a university hospital in Turkey","volume":"122","author":"Gocun","year":"2014","journal-title":"Cancer Cytopathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1507\/endocrj.EJ11-0410","article-title":"Use of molecular markers in samples obtained from preoperative aspiration of thyroid","volume":"59","author":"Adan","year":"2012","journal-title":"End. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1089\/thy.2014.0502","article-title":"For the American Thyroid Association Surgical Affairs Committee. American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules: Current Impact on Perioperative Decision Making","volume":"25","author":"Ferris","year":"2015","journal-title":"Thyroid"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1470-2045(08)70132-3","article-title":"Italian Thyroid Cancer Study Group (ITCSG). Galectin-3 expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: A prospective multicentre study","volume":"9","author":"Bartolazzi","year":"2008","journal-title":"Lancet Oncol."},{"key":"ref_21","first-page":"395","article-title":"Liquid based cytology in DNA-based molecular research","volume":"31","author":"Goncalves","year":"2009","journal-title":"Anal. Quant. Cytol. Histol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1089\/thy.2009.0240","article-title":"Molecular Diagnostics and Predictors in Thyroid Cancer","volume":"19","author":"Nikiforova","year":"2009","journal-title":"Thyroid"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1210\/jc.2009-0247","article-title":"Molecular Testing for Mutations in Improving the Fine-Needle Aspiration Diagnosis of Thyroid Nodules","volume":"94","author":"Nikiforov","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/cncy.20063","article-title":"Contribution of molecular testing to thyroid fine-needle aspiration cytology of \u201cfollicular lesion of undetermined significance\/atypia of undetermined significance\u201d","volume":"118","author":"Ohori","year":"2010","journal-title":"Cancer Cytopathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/cncy.21546","article-title":"Molecular analysis of residual ThinPrep material from thyroid FNAs increases diagnostic sensitivity","volume":"123","author":"Krane","year":"2015","journal-title":"Cancer Cytopathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/cncy.21258","article-title":"BRAF (v600e) mutation analysis on LBC-processed aspiration biopsies predicts bilaterality and nodal involvement in papillary thyroid microcarcinoma","volume":"121","author":"Rossi","year":"2013","journal-title":"Cancer Cytopathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1038\/sj.onc.1206706","article-title":"BRAF mutations and RET\/PTC rearrangements are alternative events in the ethiopathogenesis of PTC","volume":"22","author":"Soares","year":"2003","journal-title":"Oncogene"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1210\/jcem.86.5.7504","article-title":"Analysis of ret\/PTC Gene Rearrangements Refines the Fine Needle Aspiration Diagnosis of Thyroid Cancer","volume":"86","author":"Cheung","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1007\/s00268-010-0720-0","article-title":"Molecular Testing for Somatic Mutations Improves the Accuracy of Thyroid Fine-needle Aspiration Biopsy","volume":"34","author":"Moses","year":"2010","journal-title":"World J. Surg."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1007\/s00268-010-0729-4","article-title":"Detection of Papillary Thyroid Carcinoma by Analysis of BRAF and RET\/PTC1 Mutations in Fine-needle Aspiration Biopsies of Thyroid Nodules","volume":"34","author":"Musholt","year":"2010","journal-title":"World J. Surg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1159\/000333272","article-title":"BRAF Mutation Analysis of Fine-Needle Aspiration Biopsies of Papillary Thyroid Carcinoma: Impact on Diagnosis and Prognosis","volume":"55","author":"Colanta","year":"2011","journal-title":"Acta Cytol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1210\/jc.2011-1469","article-title":"Impact of Mutational Testing on the Diagnosis and Management of Patients with Cytologically Indeterminate Thyroid Nodules: A Prospective Analysis of 1056 FNA Samples","volume":"96","author":"Nikiforov","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/cncy.21474","article-title":"Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristics","volume":"122","author":"Radkay","year":"2014","journal-title":"Cancer Cytopathol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"E1852","DOI":"10.1210\/jc.2013-2292","article-title":"Targeted next-generation sequencing panel (Thyro Seq) for detection of mutations in thyroid cancer","volume":"98","author":"Nikiforova","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1002\/cncr.29038","article-title":"Highly accurate diagnosis of cancer in thyroid nodules with follicolar neoplasm\/suspicious for a follicular neoplasm cytology by Thyroseq v2 next generation sequencing assay","volume":"120","author":"Nikiforov","year":"2014","journal-title":"Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1089\/thy.2015.0305","article-title":"Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance\/Follicular Lesion of Undetermined Significance Cytology","volume":"25","author":"Nikiforov","year":"2015","journal-title":"Thyroid"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJMoa1203208","article-title":"Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology","volume":"367","author":"Alexander","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1210\/er.2007-0007","article-title":"Braf mutationin papillary thyroid cancer: Pathogenic role, molecular bases, and clinical implications","volume":"28","author":"Xing","year":"2007","journal-title":"Endocr. Rev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.tem.2007.12.003","article-title":"Clinical implications of BRAF mutation in thyroid carcinoma","volume":"19","author":"Puxeddu","year":"2008","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_40","unstructured":"Cancer Genome Atlas Research Network (2014). Integrated genomic characterization of papillary thyroid carcinoma. Cell, 159, 676\u2013690."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Ali, S., and Cibas, E.S. (2018). The Bethesda System for Reporting Thyroid Cytopathology, Springer. [2nd ed.].","DOI":"10.1007\/978-3-319-60570-8"},{"key":"ref_42","first-page":"683","article-title":"The impact of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on the performance of the Afirma gene expression classifier","volume":"125","author":"Hang","year":"2017","journal-title":"Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/cyt.12492","article-title":"Molecular pathology and thyroid FNA","volume":"28","author":"Poller","year":"2017","journal-title":"Cytopathology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/cncy.21276","article-title":"Preparation of DNA from cytological material","volume":"121","author":"Dejmek","year":"2013","journal-title":"Cancer Cytopathol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/cyt.12015","article-title":"Molecular diagnostics and the training of future tissue- and cell-based pathologists","volume":"23","author":"Catherwood","year":"2012","journal-title":"Cytopathology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/jclinpath-2011-200659","article-title":"EGFR mutations detection on liquid-based cytology: Is microscopy still necessary?","volume":"65","author":"Malapelle","year":"2012","journal-title":"J. Clin. Pathol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/jclinpath-2011-200296","article-title":"EGFR and KRAS mutations detection on lung liquid based cytology: A pilot study","volume":"65","author":"Malapelle","year":"2012","journal-title":"J. Clin. Pathol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2353\/jmoldx.2010.090238","article-title":"Archival fine-needle aspiration cytopathology (FNAC) samples: Untapped resource for clinical molecular profiling","volume":"12","author":"Killian","year":"2010","journal-title":"J. Mol. Diagn."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000329029","article-title":"Liquid-Based Cytology in Fine-Needle Aspiration Biopsies of the Thyroid Gland","volume":"55","author":"Fadda","year":"2011","journal-title":"Acta Cytol."},{"key":"ref_50","first-page":"10","article-title":"Pre-analytic steps for molecular testing on thyroid fine-needle aspirations: The goal of good results","volume":"28","author":"Rossi","year":"2013","journal-title":"CytoJournal"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.humpath.2011.04.010","article-title":"BRAF (V600E) mutation analysis of liquid-based preparation-processed fine needle aspiration sample improves the diagnostic rate of papillary thyroid carcinoma","volume":"43","author":"Chang","year":"2012","journal-title":"Hum. Pathol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.prp.2015.06.010","article-title":"Cytomorphologic features in thyroid nodules read as \u201csuspicious for malignancy\u201d on cytology may predict thyroid cancers with the BRAF mutation","volume":"211","author":"Kwon","year":"2015","journal-title":"Pathol. Res. Pr."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/cncy.20192","article-title":"The atypia of undetermined significance\/follicular lesion of undetermined significance:malignant ratio","volume":"120","author":"Krane","year":"2012","journal-title":"Cancer Cytopathol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/dc.23651","article-title":"Accuracy of international ultrasound risk stratification systems in thyroid lesions cytologically classified as indeterminate","volume":"45","author":"Trimboli","year":"2017","journal-title":"Diagn. Cytopathol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1001\/jamaoncol.2016.0386","article-title":"Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors","volume":"2","author":"Nikiforov","year":"2016","journal-title":"JAMA Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.humpath.2016.03.014","article-title":"Cytological features of \u201cinvasive follicular thyroid neoplasm with papillary-like nuclear features\u201d and their correlation with tumor histology","volume":"13","author":"Maletta","year":"2016","journal-title":"Hum. Pathol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/cncy.21631","article-title":"Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in the Bethesda system for reporting thyroid cytopathology","volume":"124","author":"Faquin","year":"2016","journal-title":"Cancer Cytopathol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1089\/thy.2015.0644","article-title":"Noninvasive Follicular Variant of Papillary Thyroid Carcinoma and the Afirma Gene-Expression Classifier","volume":"26","author":"Wong","year":"2016","journal-title":"Thyroid"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1089\/thy.2014.0612","article-title":"The Impact of Noninvasive Follicular Variant of Papillary Thyroid Carcinoma on Rates of Malignancy for Fine-Needle Aspiration Diagnostic Categories","volume":"25","author":"Strickland","year":"2015","journal-title":"Thyroid"},{"key":"ref_60","first-page":"20","article-title":"Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): Implications for the risk of malignancy (ROM) in the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC)","volume":"126","author":"Zhou","year":"2017","journal-title":"Cancer"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/thy.2010.0356","article-title":"Development of a microRNA-based molecular assay for the detection of papillary thyroid carcinoma in aspiration biopsy samples","volume":"21","author":"Mazeh","year":"2011","journal-title":"Thyroid"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/EJE-15-0817","article-title":"Diagnosis of endocrine disease: High-yield thyroid fine-needle aspiration cytology: An update focused on ancillary techniques improving its accuracy","volume":"174","author":"Bongiovanni","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1089\/thy.2018.0394","article-title":"Cytological Diagnoses Associated with Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features According to the Bethesda System for Reporting Thyroid Cytopathology: A Systematic Review and Meta-Analysis","volume":"29","author":"Bongiovanni","year":"2019","journal-title":"Thyroid"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Bongiovanni, M., Faquin, W., Giovanella, L., Durante, C., Kopp, P., and Trimboli, P. (2019). Impact of non-invasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTP) on risk of malignancy in patients undergoing lobectomy\/thyroidectomy for suspicious for malignancy or malignant fine-needle aspiration cytology findings: A systematic review and meta-analysis. Eur. J. Endocrinol.","DOI":"10.1530\/EJE-19-0223"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"52475","DOI":"10.18632\/oncotarget.9655","article-title":"miRNA expression and function in thyroid carcinomas: A comparative and critical analysis and a model for other cancers","volume":"7","author":"Saiselet","year":"2016","journal-title":"Oncotarget"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1089\/thy.2011.0081","article-title":"MicroRNA Signature in Thyroid Fine Needle Aspiration Cytology Applied to \u201cAtypia of Undetermined Significance\u201d Cases","volume":"22","author":"Shen","year":"2012","journal-title":"Thyroid"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/thy.2011.0313","article-title":"MicroRNA expression profiles in thyroid microRNAs in thyroid fine needle aspiration biopsy samples","volume":"22","author":"Nikiforova","year":"2012","journal-title":"Thyroid"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1210\/jc.2007-2696","article-title":"MicroRNA Expression Profiling of Thyroid Tumors: Biological Significance and Diagnostic Utility","volume":"93","author":"Nikiforova","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jss.2012.04.051","article-title":"Differentiating benign from malignant thyroid nodules using micro ribonucleic acid amplification in residual cells obtained by fine needle aspiration biopsy","volume":"180","author":"Mazeh","year":"2013","journal-title":"J. Surg. Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1586\/14737159.2013.811893","article-title":"Molecular diagnosis for indeterminate thyroid nodules on fine needle aspiration: Advances and limitations","volume":"13","author":"Keutgen","year":"2013","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1677\/erc.1.01209","article-title":"MircoRNA deregulation in human thyroid papillary carcinomas","volume":"13","author":"Pallante","year":"2006","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1530\/EJE-12-0400","article-title":"MicroRNA expression profile helps to distinguish benign nodules from papillary thyroid carcinomas starting from cells of fine-needle aspiration","volume":"167","author":"Agretti","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"9343","DOI":"10.1007\/s13277-014-2209-1","article-title":"Diagnostic value of microRNAs in discriminating malignant thyroid nodules from benign ones on fine-needle aspiration samples","volume":"35","author":"Zhang","year":"2014","journal-title":"Tumor Boil."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1089\/thy.2012.0632","article-title":"Comprehensive MicroRNA Expression Profiling Identifies Novel Markers in Follicular Variant of Papillary Thyroid Carcinoma","volume":"23","author":"Dettmer","year":"2013","journal-title":"Thyroid"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1210\/jc.2012-2694","article-title":"MicroRNA expression array identifies novel diagnostic markers for conventional and oncocytic follicular thyroid carcinomas","volume":"98","author":"Dettmer","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s12020-016-0866-0","article-title":"The evaluation of miRNAs on thyroid FNAC: The promising role of miR-375 in follicular neoplasms","volume":"54","author":"Rossi","year":"2016","journal-title":"Endocrine"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1210\/jc.2016-1155","article-title":"A 2015 Survey of Clinical Practice Patterns in the Management of Thyroid Nodules","volume":"101","author":"Burch","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/cncy.21731","article-title":"Analytical validity of a microRNA-based assay for diagnosing indeterminate thyroid FNA smears from routinely prepared cytology slides","volume":"124","author":"Benjamin","year":"2016","journal-title":"Cancer Cytopathol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/his.12461","article-title":"Next-generation sequencing improves the diagnosis of thyroid FNA specimens with indeterminate cytology","volume":"66","author":"Blanchard","year":"2015","journal-title":"Histopathology"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/cncy.22112","article-title":"Clinical validation of the ThyroSeq V3 genomic classifier in thyroid nodules with indeterminate FNA cytology","volume":"127","author":"Nikiforov","year":"2019","journal-title":"Cancer Cytopathol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1002\/cncr.31245","article-title":"Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules","volume":"124","author":"Nikiforova","year":"2018","journal-title":"Cancer"},{"key":"ref_82","first-page":"14","article-title":"Molecular cytopathology for thyroid nodules: A review of methodology and test performance","volume":"124","author":"Nishino","year":"2016","journal-title":"Cancer"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/cncy.22012","article-title":"Ancillary molecular testing of indeterminate thyroid nodules","volume":"126","author":"Rossi","year":"2018","journal-title":"Cancer Cytopathol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/cncy.22088","article-title":"Benign call rate and molecular test result distribution in ThyroSeq V3","volume":"127","author":"Ohori","year":"2019","journal-title":"Cancer Cytopathol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1210\/jc.2013-3584","article-title":"An Independent Study of a Gene Expression Classifier (Afirma) in the Evaluation of Cytologically Indeterminate Thyroid Nodules","volume":"99","author":"McIver","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s00268-013-2430-x","article-title":"Potential Effects of Molecular Testing of Indeterminate Thyroid Nodule Fine Needle Aspiration Biopsy on Thyroidectomy Volume","volume":"38","author":"Dedhia","year":"2014","journal-title":"World J. Surg."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4274\/2017.26.suppl.05","article-title":"Molecular Profiling of Thyroid Nodules: Current Role for the Afirma Gene Expression Classifier on Clinical Decision Making","volume":"26","author":"Kloos","year":"2017","journal-title":"Mol. Imaging Radionucl. Ther."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"985","DOI":"10.5858\/arpa.2016-0328-OA","article-title":"Evaluation of the Afirma Gene Expression Classifier in Repeat Indeterminate Thyroid Nodules","volume":"141","author":"Harrison","year":"2017","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/cncy.21827","article-title":"Qualifiers of atypia in the cytologic diagnosis of thyroid nodules are associated with different Afirma gene expression classifier results and clinical outcomes","volume":"125","author":"Baca","year":"2017","journal-title":"Cancer Cytopathol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1245\/s10434-015-4486-3","article-title":"Wide Inter-institutional Variation in Performance of a Molecular Classifier for Indeterminate Thyroid Nodules","volume":"22","author":"Marti","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.surg.2017.10.004","article-title":"Cost-effectiveness of lobectomy versus genetic testing (Afirma\u00ae) for indeterminate thyroid nodules: Considering the costs of surveillance","volume":"163","author":"Balentine","year":"2018","journal-title":"Surgery"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Hao, Y., Duh, Q.Y., Kloos, R.T., Babiarz, J., Harrell, R.M., Traweek, S.T., Kim, S.Y., Fedorowicz, G., Walsh, P.S., and Sadow, P.M. (2019). Identification of H\u00fcrthle cell cancers: Solving a clinical challenge with genomic sequencing and a trio of machine learning algorithms. BMC Syst. Boil., 13.","DOI":"10.1186\/s12918-019-0693-z"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1089\/thy.2018.0726","article-title":"Independent Comparison of the Afirma Genomic Sequencing Classifier and Gene Expression Classifier for Cytologically Indeterminate Thyroid Nodules","volume":"29","author":"Angell","year":"2019","journal-title":"Thyroid"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1089\/thy.2018.0733","article-title":"Afirma Gene Sequencing Classifier Compared with Gene Expression Classifier in Indeterminate Thyroid Nodules","volume":"29","author":"Endo","year":"2019","journal-title":"Thyroid"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1089\/thy.2015.0049","article-title":"Performance of the Afirma Gene Expression Classifier in H\u00fcrthle Cell Thyroid Nodules Differs from Other Indeterminate Thyroid Nodules","volume":"25","author":"Brauner","year":"2015","journal-title":"Thyroid"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/jclinpath-2016-204089","article-title":"Multicentre validation of a microRNA-based assay for diagnosing indeterminate thyroid nodules utilizing fine needle aspirate smears","volume":"70","author":"Dromi","year":"2017","journal-title":"J. Clin. Pathol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1158\/1078-0432.CCR-11-2487","article-title":"A Panel of Four miRNAs Accurately Differentiates Malignant from Benign Indeterminate Thyroid Lesions on Fine Needle Aspiration","volume":"18","author":"Keutgen","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1210\/jc.2015-1158","article-title":"Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology","volume":"100","author":"Labourier","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/cjp2.38","article-title":"Molecular classification of thyroid lesions by combined testing for miRNA gene expression and somatic gene alterations","volume":"2","author":"Wylie","year":"2016","journal-title":"J. Pathol. Clin. Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/cncy.21333","article-title":"\u201cColloid-rich\u201d follicular neoplasm\/suspicious for follicular neoplasm thyroid fine-needle aspiration specimens: Cytologic, histologic, and molecular basis for considering an alternate view","volume":"121","author":"Ohori","year":"2013","journal-title":"Cancer Cytopathol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/cncy.21554","article-title":"Malignant risk stratification of thyroid FNA specimens with indeterminate cytology based on molecular testing","volume":"123","author":"Paskas","year":"2015","journal-title":"Cancer Cytopathol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/PAP.0000000000000135","article-title":"Cytopathology of Follicular Cell Nodules","volume":"24","author":"Rossi","year":"2017","journal-title":"Adv Anat Pathol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/cncy.21605","article-title":"A meta-analytic review of the Bethesda System for Reporting Thyroid Cytopathology: Has the rate of malignancy in indeterminate lesions been underestimated?","volume":"123","author":"Straccia","year":"2015","journal-title":"Cancer Cytopathol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1002\/hed.23829","article-title":"Utility of BRAF mutation detection in fine-needle aspiration biopsy samples read as \u201csuspicious for papillary thyroid carcinoma\u201d","volume":"37","author":"Jara","year":"2015","journal-title":"Head Neck"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Lau, R.P., Paulsen, J.D., Brandler, T.C., Liu, C.Z., Simsir, A., and Zhou, F. (2017). Impact of the Reclassification of \u201cNoninvasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma\u201d to \u201cNoninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features\u201d on the Bethesda System for Reporting Thyroid Cytopathology: A Large Academic Institution\u2019s Experience. Am. J. Clin. Pathol.","DOI":"10.1093\/ajcp\/aqx136"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000469654","article-title":"Impact of the Reclassification of the Non-Invasive Follicular Variant of Papillary Carcinoma as Benign on the Malignancy Risk of the Bethesda System for Reporting Thyroid Cytopathology: A Meta-Analysis Study","volume":"61","author":"Esebua","year":"2017","journal-title":"Acta Cytol."},{"key":"ref_107","first-page":"116A","article-title":"Impact of New Nomenclature \u201cNon-Invasive Follicular Neoplasm with Papillary Like Nuclear Features\u201d on the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC). An Institutional Experience","volume":"30","author":"Shahi","year":"2017","journal-title":"Mod. Pathol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/cncy.21777","article-title":"Young investigator challenge: The morphologic analysis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on liquid-based cytology: Some insights into their identification","volume":"124","author":"Bizzarro","year":"2016","journal-title":"Cancer Cytopathol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/dc.23709","article-title":"Sonographic and cytologic differences of NIFTP from infiltrative or invasive encapsulated follicular variant of papillary thyroid carcinoma: A Review of 179 Cases","volume":"45","author":"Yang","year":"2017","journal-title":"Diagn. Cytopathol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/cncy.21802","article-title":"Young Investigator Challenge: Molecular testing in noninvasive follicular thyroid neoplasm with papillary-like nuclear features","volume":"124","author":"Jiang","year":"2016","journal-title":"Cancer Cytopathol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/cyt.12501","article-title":"Pre-operative features of non-invasive follicular thyroid neoplasms with papillary-like nuclear features: An analysis of their cytological, Gene Expression Classifier and sonographic findings","volume":"28","author":"Song","year":"2017","journal-title":"Cytopathology"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/PAP.0000000000000163","article-title":"The molecular landscape of non invasive follicular thyroid neoplasm with papillary like-nuclear features (NIFTP): A literature review","volume":"24","author":"Basolo","year":"2017","journal-title":"Adv. Anat. Pathol."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Kim, T.H., Lee, M., Kwon, A.Y., Choe, J.H., Kim, J.H., Kim, J.S., Hahn, S.Y., Shin, J.H., Chung, M.K., and Son, Y.I. (2017). Molecular genotyping of the non-invasive encapsulated follicular variant of papillary thyroid carcinoma. Histopathology.","DOI":"10.1111\/his.13401"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Steward, D.L., Carty, S.E., Sippel, R.S., Yang, S.P., Sosa, J.A., Sipos, J.A., Figge, J.J., Mandel, S., Haugen, B.R., and Burmen, K.D. (2018). Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study. JAMA Oncol.","DOI":"10.1001\/jamaoncol.2018.4616"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3389\/fendo.2018.00179","article-title":"Preoperative Molecular Markers in Thyroid Nodules","volume":"9","author":"Sahli","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/10\/10\/736\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:23:15Z","timestamp":1760188995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/10\/10\/736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,23]]},"references-count":115,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10]]}},"alternative-id":["genes10100736"],"URL":"https:\/\/doi.org\/10.3390\/genes10100736","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,23]]}}}